Condition
Gyrate Atrophy
Total Trials
4
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Completed2
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02435940Recruiting
Inherited Retinal Degenerative Disease Registry
NCT05312736Active Not RecruitingPrimary
Gyrate Atrophy Ocular and Systemic Study
NCT00001166CompletedPrimary
Gyrate Atrophy of the Choroid and Retina
NCT00001735Phase 1CompletedPrimary
Gene Therapy for Gyrate Atrophy
Showing all 4 trials